NCT06792929

Brief Summary

Thyroid nodules are a common health problem in the adult population. The majority of cancers are diagnosed by thyroid fine needle aspiration biopsy. Thyroid nodules generally show clinical findings in 1-5% of cases on physical examination and 20-70% on ultrasound examination. In diagnosis; Ultrasonography, fine needle aspiration biopsy, ultrasonography-guided fine needle aspiration biopsy, scintigraphy, computed tomography and magnetic resonance imaging are widely used. The fact that the thyroid fine needle aspiration biopsy procedure is painful, there is no speaking or coughing during the procedure, and in case of insufficient sample, the procedure must be performed several times. Its repetition causes fear and anxiety in patients. A combination of pharmacological and nonpharmacological methods for pain control likely provides the most effective pain relief for the patient. Distraction is one of the non-pharmacological methods used in pain control. Distraction is one of the most preferred methods to reduce pain in patients during diagnosis and treatment procedures. It is a method that allows patients to control and reduce the symptoms they experience by focusing their attention on a different point.The aim of this study is to examine the effect of using a motivational video with virtual reality glasses to distract attention during the biopsy procedure on pain, stress and fear in individuals with suspected thyroid cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 27, 2025

Completed
29 days until next milestone

Study Start

First participant enrolled

February 25, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

January 27, 2025

Status Verified

January 1, 2025

Enrollment Period

2 months

First QC Date

January 18, 2025

Last Update Submit

January 24, 2025

Conditions

Keywords

Thyroid CancerVirtual Reality TherapyUltrasoundThyroid NoduleFine needle aspiration biopsy

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    The scale is used to assess subjectively perceived pain. It is a 10 cm (100 mm) ruler with no pain on one end and the "most severe pain" on the other. The individuals participating in the study are asked to mark the intensity of pain they are currently feeling, explaining that the number "0" on the scale means "I feel no pain" and that the intensity of pain increases as the numbers increase, and the number "10" means "I feel the most severe pain". An increase in the score obtained from the scale in the assessment indicates that the pain is increasing. Each patient will be administered two times.

    Before and immediately after ultrasound guided fine needle aspiration biopsy procedure

Secondary Outcomes (2)

  • Fear of Pain Scale-III

    Before and immediately after ultrasound guided fine needle aspiration biopsy procedure

  • Beck Anxiety Scale

    Before and immediately after ultrasound guided fine needle aspiration biopsy procedure

Study Arms (2)

virtual reality glasses group

EXPERIMENTAL

Patients will wear virtual reality glasses throughout the ultrasound-guided fine needle aspiration biopsy procedure.

Device: virtual reality glasses group

Control group

NO INTERVENTION

patients without of virtual reality glasses

Interventions

Patients will wear virtual reality glasses throughout the ultrasound-guided fine needle aspiration biopsy procedure.

virtual reality glasses group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with suspected thyroid mass
  • No dizziness problem
  • No vision problems

You may not qualify if:

  • Mental health problems that may prevent wearing virtual reality glasses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dicle Univertsity

Diyarbakır, South East, 21100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid NoduleDisease

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
They do not know the experimental or control procedures that take place
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: virtual reality glasses group and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 18, 2025

First Posted

January 27, 2025

Study Start

February 25, 2025

Primary Completion

April 30, 2025

Study Completion

August 30, 2025

Last Updated

January 27, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations